|
Re: MannKind Receives “Market Perform” Rating from Wells Fargo (MNKD)
|
1
|
Mannkind
|
Mar 12, 2013 09:59AM
|
|
Re: MannKind Corporation: Reasons to believe in the future article
|
|
Mannkind
|
Mar 20, 2012 09:25AM
|
|
Re: MannKind Corporation to Hold 2013 First Quarter Financial Results Conference Cal
|
2
|
Mannkind
|
May 03, 2013 08:59AM
|
|
Re: MannKind Corporation Implements BioPharm Systems’ Siebel Clinical Trial
|
|
Mannkind
|
Jul 23, 2013 10:45AM
|
|
Re: MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 DM
|
1
|
Mannkind
|
Jun 17, 2013 09:00AM
|
|
Re: MannKind CFO says will consider partnering after examining data
|
|
Mannkind
|
Jun 18, 2013 04:27PM
|
|
Re: MannKind Assigned Patent
|
1
|
Mannkind
|
Oct 08, 2012 08:51AM
|
|
Re: MannKind ASM Notes
|
2
|
Mannkind
|
May 18, 2012 11:19AM
|
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 02, 2013 11:36AM
|
|
Re: MannKind announces $160M debt financing
|
2
|
Mannkind
|
Jul 01, 2013 05:05PM
|
|
Re: MannKind announces $160M debt financing
|
4
|
Mannkind
|
Jul 01, 2013 09:45AM
|
|
Re: MannKind and TechnoVax????
|
1
|
Mannkind
|
Mar 27, 2013 09:14AM
|
|
Re: Mannkind (MNKD) Files to Offer $50M in Stock
|
1
|
Mannkind
|
Mar 18, 2013 05:40PM
|
|
Re: Mann Group Transaction+
|
|
Mannkind
|
Oct 18, 2012 03:22PM
|
|
Re: Mann Group Transaction+
|
1
|
Mannkind
|
Oct 18, 2012 05:45PM
|
|
Re: Management...
|
|
Mannkind
|
Aug 10, 2012 08:54AM
|
|
Re: Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
|
Mannkind
|
Jun 28, 2013 09:56AM
|
|
Re: Little top heavy?
|
|
Mannkind
|
Jan 07, 2013 05:00PM
|
|
Re: Linking HF to clinical trials
|
|
Mannkind
|
May 02, 2013 08:55AM
|
|
Re: Lilly bets on new insulin products with $180M plant addition
|
1
|
Mannkind
|
Apr 02, 2013 03:59PM
|
